Medications for Nonsquamous Nonsmall Cell Lung Cancer

3 results

  • avastin

    (bevacizumab)
    Genentech, Inc.
    Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.

  • emrelis

    (Telisotuzumab Vedotin)
    AbbVie Inc.
    EMRELIS is indicated for adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) exhibiting high c-Met protein overexpression (≥50% of tumor cells). It is for those who have previously received systemic therapy and is approved under accelerated conditions based on overall response rate.

  • zirabev

    (bevacizumab-bvzr)
    Pfizer Laboratories Div Pfizer Inc
    ZIRABEV is indicated for treating metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer, and advanced epithelial ovarian/fallopian tube/peritoneal cancer, often in combination with other chemotherapy agents.